Brevital Sodium (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Brevital Sodium drug offered from Par Pharmaceutical, Inc.. This Barbiturate [EPC],Barbiturates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | methohexital sodium |
| SUBSTANCE NAME: | METHOHEXITAL SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Barbiturate [EPC],Barbiturates [Chemical/Ingredient] |
| ROUTE: | INTRAMUSCULAR; INTRAVENOUS; RECTAL |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-11-01 |
| END MARKETING DATE: | 0000-00-00 |
Brevital Sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Brevital Sodium from Par Pharmaceutical, Inc. |
| LABELER NAME: | Par Pharmaceutical, Inc. |
| DEA SCHEDULE: | CIV
|
| ACTIVE STRENGTH: | 500(mg/1) |
| START MARKETING DATE: | 2007-11-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42023-105_e387f9d3-5b2e-4359-88ab-1ce750c42c66 |
| PRODUCT NDC: | 42023-105 |
| APPLICATION NUMBER: | NDA011559 |
Other METHOHEXITAL SODIUM Pharmaceutical Manufacturers / Labelers:
